PL365281A1 - Sposób wytwarzania Clopidogrelu - Google Patents

Sposób wytwarzania Clopidogrelu

Info

Publication number
PL365281A1
PL365281A1 PL02365281A PL36528102A PL365281A1 PL 365281 A1 PL365281 A1 PL 365281A1 PL 02365281 A PL02365281 A PL 02365281A PL 36528102 A PL36528102 A PL 36528102A PL 365281 A1 PL365281 A1 PL 365281A1
Authority
PL
Poland
Prior art keywords
optically active
compounds
racemic
formula
bromine
Prior art date
Application number
PL02365281A
Other languages
English (en)
Inventor
Bipin Pandey
Vidya Bhushan Lohray
Braj Bhushan Lohray
Original Assignee
Cadila Healthcare Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26324902&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365281(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IN84MU2001 external-priority patent/IN191030B/en
Application filed by Cadila Healthcare Ltd. filed Critical Cadila Healthcare Ltd.
Publication of PL365281A1 publication Critical patent/PL365281A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL02365281A 2001-01-24 2002-01-21 Sposób wytwarzania Clopidogrelu PL365281A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN84MU2001 IN191030B (pl) 2001-01-24 2001-01-24
US10/054,101 US6635763B2 (en) 2001-01-24 2001-10-22 Process to prepare clopidogrel

Publications (1)

Publication Number Publication Date
PL365281A1 true PL365281A1 (pl) 2004-12-27

Family

ID=26324902

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02365281A PL365281A1 (pl) 2001-01-24 2002-01-21 Sposób wytwarzania Clopidogrelu

Country Status (17)

Country Link
EP (1) EP1353928B1 (pl)
JP (1) JP5000841B2 (pl)
KR (1) KR20060040758A (pl)
CN (1) CN100338068C (pl)
AT (1) ATE349451T1 (pl)
AU (1) AU2002228325B2 (pl)
BR (1) BR0207064A (pl)
CA (1) CA2436323C (pl)
CY (1) CY1106346T1 (pl)
DE (1) DE60217062T2 (pl)
DK (1) DK1353928T3 (pl)
EA (1) EA006198B2 (pl)
ES (1) ES2278010T3 (pl)
MX (1) MXPA03006133A (pl)
NO (1) NO327807B1 (pl)
PL (1) PL365281A1 (pl)
WO (1) WO2002059128A2 (pl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191030B (pl) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
EP1606231A1 (en) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Process for preparation of clopidogrel, its salts and pharmaceutical compositions
WO2005003138A2 (en) 2003-07-02 2005-01-13 EGIS Gyógyszergyár Rt. Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
KR101155679B1 (ko) * 2003-07-02 2012-06-13 에지스 지오기스제르기아르 니일바노산 무코도 레스즈베니타르사사그 혈소판 응집 억제제 약물의 결정성 다형체를 제조하는 방법
US8907090B2 (en) 2003-11-03 2014-12-09 Cadila Healthcare Limited Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
EP1732932B1 (en) 2004-04-09 2012-03-21 Hanmi Holdings Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
CZ20041048A3 (cs) * 2004-10-18 2005-11-16 Zentiva, A. S Způsob výroby klopidogrelu
CN100406568C (zh) * 2005-02-18 2008-07-30 淮北市辉克药业有限公司 氯吡格雷新生产工艺
CZ299213B6 (cs) * 2005-03-08 2008-05-21 Zentiva, A. S Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové
KR100678287B1 (ko) 2005-06-23 2007-02-02 한미약품 주식회사 클로피도그렐의 제조방법 및 이에 사용되는 중간체
CN100463909C (zh) * 2005-09-08 2009-02-25 浙江华海药业股份有限公司 一种噻吩并四氢吡啶乙腈化合物的合成方法
WO2007028337A1 (en) * 2005-09-08 2007-03-15 Zhejiang Huahai Pharmaceutical Co., Ltd. Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds
CN100417653C (zh) * 2005-09-08 2008-09-10 浙江华海药业股份有限公司 噻吩并四氢吡啶乙酸及其盐的制备方法
CN100390180C (zh) * 2005-12-15 2008-05-28 上海应用技术学院 氯吡格雷及其盐的制备方法
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
CN100396687C (zh) * 2006-05-26 2008-06-25 浙江海翔药业股份有限公司 (+)-(s-)-氯吡格雷硫酸氢盐(i型)的制备方法
WO2007144895A1 (en) * 2006-06-12 2007-12-21 Cadila Healthcare Limited Process for the preparation of (s) - (+)-clopidogrel
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
PL380849A1 (pl) * 2006-10-17 2008-04-28 Adamed Spółka Z Ograniczoną Odpowiedzialnością Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie
US7985859B2 (en) 2007-05-30 2011-07-26 Wockhardt Ltd. Processes for the preparation of clopidogrel
CA2709262A1 (en) * 2007-12-14 2009-06-25 Generics [Uk] Limited New hplc method
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
KR100990949B1 (ko) * 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
CN101787033B (zh) * 2010-03-16 2011-08-31 天津市中央药业有限公司 一种硫酸氢氯吡格雷有关物质c的合成方法
CN101812071A (zh) * 2010-05-10 2010-08-25 杭州和素化学技术有限公司 硫酸氢氯吡格雷中间体拆分后的母液处理方法
CN102241690B (zh) 2010-05-13 2015-08-12 天津药物研究院 一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
CN101845050A (zh) * 2010-06-01 2010-09-29 上虞京新药业有限公司 一种氯吡格雷的制备方法
CN101962388B (zh) * 2010-10-14 2012-12-19 天津药物研究院 乙酰胺衍生物及其制备方法和用途
CN101974016A (zh) * 2010-10-14 2011-02-16 天津药物研究院 酰胺类化合物及其制备方法和用途
CN104045652A (zh) * 2014-07-09 2014-09-17 沈健芬 一种氯吡格雷中间体的制备方法
CN110627808B (zh) * 2018-06-21 2022-04-01 江苏同禾药业有限公司 一种硫酸氢氯吡格雷拆分母液的回收处理工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
JPS5980664A (ja) * 1982-09-30 1984-05-10 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
JPS60112762A (ja) * 1983-11-21 1985-06-19 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.

Also Published As

Publication number Publication date
ATE349451T1 (de) 2007-01-15
NO20032898L (no) 2003-09-03
AU2002228325B2 (en) 2006-05-04
DE60217062T2 (de) 2007-06-21
CN100338068C (zh) 2007-09-19
EP1353928A2 (en) 2003-10-22
CA2436323C (en) 2012-02-21
MXPA03006133A (es) 2004-05-04
EA006198B2 (ru) 2007-10-26
EA200300831A1 (ru) 2003-12-25
DE60217062D1 (de) 2007-02-08
EA006198B1 (ru) 2005-10-27
KR20060040758A (ko) 2006-05-10
JP2004522744A (ja) 2004-07-29
BR0207064A (pt) 2004-03-30
NO20032898D0 (no) 2003-06-24
CA2436323A1 (en) 2002-08-01
CY1106346T1 (el) 2011-10-12
DK1353928T3 (da) 2007-03-26
ES2278010T3 (es) 2007-08-01
CN1487943A (zh) 2004-04-07
JP5000841B2 (ja) 2012-08-15
NO327807B1 (no) 2009-09-28
WO2002059128A2 (en) 2002-08-01
WO2002059128A3 (en) 2002-12-19
EP1353928B1 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
EA006198B2 (ru) Способ получения клопидогрела
HU9503719D0 (en) Piperidine derivatives and process for their production
HUP0104646A2 (hu) Fuzionált 1,2,4-tiadiazin-származékok, azok előállítása és felhasználása
DE60130562D1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
HUP0100287A2 (hu) Rákellenes hatású tienopirimidin- és tienopiridin-származékok
WO2007018738A8 (en) Fused bicycloheterocycle substituted quinuclidine derivatives
DK1159279T3 (da) 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
HUP0400527A2 (hu) Benzoil-piridin-származékok vagy sóik, ezeket aktív alkotórészként tartalmazó fungicidek, eljárás ezek előállítására, és köztes termékek ezek előállításához
AP2001002309A0 (en) 1-amino triazolo[4,3-A] quinazoline-5-ones and/or-5-thiones inhibiting phosphodiesterase IV.
NO305555B1 (no) Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel
IL143105A0 (en) Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same
HUP9904034A2 (hu) Új eljárás fenil-imidazolidin-származékok előállítására
EP1473295A4 (en) BICYCLIC FUSIONED PYRIMIDINE DERIVATIVES
YU72000A (sh) Kompleks platine, njegovo dobijanje i terapeutska primena
HUP0203364A2 (hu) Eljárás 3-helyettesített-4-arilkinolin-2-on származékok előállítására
ATE299506T1 (de) Verfahren zur herstellung von pyrazolo(1,5- b)pyridazin-derivaten
DK1440075T3 (da) Hidtil ukendte heteroaromatiske 3beta-aminio-azabicyclooctan-amidderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
HUP0300758A2 (hu) Kalcilitikus vegyületek és alkalmazásuk kalciumreceptor antagonistákként
PL327927A1 (en) Derivatives of pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine, their production and application
MY130997A (en) Photochromic oxazine compounds and methods for their manufacture
EP1496059A4 (en) CONDENSED BICYCLIC PYRIMIDINE DERIVATIVES
IL158839A0 (en) DIHYDROIMIDAZO [5,1-A]-beta-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE
AU1370895A (en) 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug
WO2002020498A3 (en) An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)